Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AGIO Agios Pharmaceuticals, Inc.

交易中 12-17 11:15:51 EST

25.99

-0.10

-0.38%

最高26.36	最低25.65	成交量26.93万
今开26.19	昨收26.09	日振幅2.72%
总市值15.16亿	流通市值13.35亿	总股本5,831万
成交额698.03万	换手率0.52%	流通股本5,135万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AGIO","market":"US","secType":"STK","nameCN":"Agios Pharmaceuticals, Inc.","latestPrice":25.99,"timestamp":1765988145178,"preClose":26.09,"halted":0,"volume":269345,"delay":0,"floatShares":51348506,"shares":58313812,"eps":-6.962485,"marketStatus":"交易中","change":-0.1,"latestTime":"12-17 11:15:51 EST","open":26.19,"high":26.36,"low":25.65,"amount":6980258.8296,"amplitude":0.027213,"askPrice":26,"askSize":45,"bidPrice":25.92,"bidSize":22,"shortable":3,"etf":0,"ttmEps":-6.962485,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766005200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1374638400000,"exchange":"NASDAQ","adjPreClose":26.09,"preHourTrading":{"tag":"盘前","latestPrice":26.23,"preClose":26.09,"latestTime":"09:29 EST","volume":274,"amount":7283.00631,"timestamp":1765981770085},"postHourTrading":{"tag":"盘后","latestPrice":26.06,"preClose":26.09,"latestTime":"19:33 EST","volume":89447,"amount":2333667.39,"timestamp":1765931620110},"volumeRatio":0.754572,"impliedVol":0.6358,"impliedVolPercentile":0.564},"requestUrl":"/m/hq/s/AGIO","defaultTab":"news","newsList":[{"id":"2586231238","title":"Agios Pharmaceuticals, Inc.盘中异动 临近午盘大幅拉升5.08%报27.84美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586231238","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586231238?lang=zh_cn&edition=full","pubTime":"2025-11-26 00:47","pubTimestamp":1764089237,"startTime":"0","endTime":"0","summary":"北京时间2025年11月26日00时47分，Agios Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.08%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家专注于细胞代谢领域的生物制药公司，旨在为罕见疾病开发差异化药物，其研究重点是经典血液学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126004717a7110a28&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251126004717a7110a28&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2584180017","title":"Agios Pharmaceuticals, Inc.股价重挫50.21% 市值跌6.63亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584180017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584180017?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:31","pubTimestamp":1763562687,"startTime":"0","endTime":"0","summary":"北京时间2025年11月19日22时31分，Agios Pharmaceuticals, Inc.股票出现波动，股价急速下跌50.21%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Kazia Therapeutics Limited、Biovie Inc C/Wts 08/08/2030、Fulcrum Therapeutics, Inc.涨幅较大，Kazia Therapeutics Limited、Clearmind Medicine Inc.、Can Fite Biopharma Ltd较为活跃，换手率分别为793.20%、68.35%、23.45%，振幅较大的相关个股有Bioatla, Inc.、Fulcrum Therapeutics, Inc.、冠科美博，振幅分别为9.84%、9.15%、8.04%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家专注于细胞代谢领域的生物制药公司，旨在为罕见疾病开发差异化药物，其研究重点是经典血液学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119223127a4ad1185&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251119223127a4ad1185&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"1125155038","title":"Agios公司公布镰状细胞贫血症研究结果喜忧参半，引发对该药物未来前景担忧","url":"https://stock-news.laohu8.com/highlight/detail?id=1125155038","media":"老虎资讯综合","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125155038?lang=zh_cn&edition=full","pubTime":"2025-11-19 21:17","pubTimestamp":1763558255,"startTime":"0","endTime":"0","summary":"11月19日，Agios Pharmaceuticals盘前跌近59%！周三公布了一项针对镰状细胞病的 3 期研究结果喜忧参半，这可能会降低其药物获得美国批准的希望。 在为期一年的研究中，接受 Agios 药物 Pyrukynd 治疗的患者中有 41% 的血红蛋白水平得到改善，而接受安慰剂治疗的参与者中只有 3% 的人达到了这一改善——这一结果具有统计学意义，并实现了两个主要研究目标之一。 ","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Agios公司公布镰状细胞贫血症研究结果喜忧参半，引发对该药物未来前景担忧","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO"],"gpt_icon":0},{"id":"1140122793","title":"Agios Pharmaceuticals股价盘前下跌35.1%，因晚期镰状细胞药物试验未能实现主要目标之一","url":"https://stock-news.laohu8.com/highlight/detail?id=1140122793","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140122793?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:22","pubTimestamp":1763554935,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals股价盘前下跌35.1%，因晚期镰状细胞药物试验未能实现主要目标之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5d18614bb841112089a87d6203a0bc12","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"1168351762","title":"Agios：试验显示Mitapivat有利趋势，但在年度Scpcs发生率的主要终点上未达到统计显著性","url":"https://stock-news.laohu8.com/highlight/detail?id=1168351762","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168351762?lang=zh_cn&edition=full","pubTime":"2025-11-19 20:02","pubTimestamp":1763553752,"startTime":"0","endTime":"0","summary":"Agios：试验显示Mitapivat有利趋势，但在年度Scpcs发生率的主要终点上未达到统计显著性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2565587401","title":"Agios Pharmaceuticals, Inc.盘中异动 早盘股价大跌13.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2565587401","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565587401?lang=zh_cn&edition=full","pubTime":"2025-09-04 21:31","pubTimestamp":1756992662,"startTime":"0","endTime":"0","summary":"北京时间2025年09月04日21时31分，Agios Pharmaceuticals, Inc.股票出现波动，股价急速跳水13.26%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家专注于细胞代谢领域的生物制药公司，旨在为罕见疾病开发差异化药物，其研究重点是经典血液学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904213102a4b40dd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250904213102a4b40dd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2558057689","title":"Agios Pharmaceuticals, Inc.2025财年第二财季实现净利润-1.12亿美元，同比减少16.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558057689","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558057689?lang=zh_cn&edition=full","pubTime":"2025-08-09 00:00","pubTimestamp":1754668842,"startTime":"0","endTime":"0","summary":"8月9日，Agios Pharmaceuticals, Inc.公布财报，公告显示公司2025财年第二财季净利润为-1.12亿美元，同比减少16.52%；其中营业收入为12.46百万美元，同比增加44.55%，每股基本收益为-1.93美元。机构评级：截至2025年8月9日，当前有7家机构对Agios Pharmaceuticals, Inc.目标价做出预测，其中目标均价为50.14美元，其中最低目标价为37.00美元，最高目标价为65.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809000105a47d91a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809000105a47d91a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO"],"gpt_icon":0},{"id":"2556909382","title":"Agios Pharmaceuticals, Inc.股价重挫12.83% 市值跌2.27亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556909382","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556909382?lang=zh_cn&edition=full","pubTime":"2025-08-04 21:32","pubTimestamp":1754314341,"startTime":"0","endTime":"0","summary":"北京时间2025年08月04日21时32分，Agios Pharmaceuticals, Inc.股票出现异动，股价大幅跳水12.83%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，Psyence Biomedical Ltd.、Soligenix, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为2217.65%、801.47%、388.27%，振幅较大的相关个股有Psyence Biomedical Ltd.、凯信远达、Bioxcel Therapeutics, Inc.，振幅分别为21.40%、15.35%、13.50%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家专注于细胞代谢领域的生物制药公司，旨在为罕见疾病开发差异化药物，其研究重点是经典血液学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213222a4748fc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804213222a4748fc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2556429810","title":"Agios Pharmaceuticals, Inc.盘中异动 大幅跳水5.00%报35.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556429810","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556429810?lang=zh_cn&edition=full","pubTime":"2025-08-02 00:50","pubTimestamp":1754067038,"startTime":"0","endTime":"0","summary":"北京时间2025年08月02日00时50分，Agios Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.00%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家专注于细胞代谢领域的生物制药公司，旨在为罕见疾病开发差异化药物，其研究重点是经典血液学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802005038972d52f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802005038972d52f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2555570675","title":"Agios Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555570675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555570675?lang=zh_cn&edition=full","pubTime":"2025-07-29 03:28","pubTimestamp":1753730906,"startTime":"0","endTime":"0","summary":"北京时间2025年07月29日03时28分，Agios Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.05%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.39%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家专注于细胞代谢领域的生物制药公司，旨在为罕见疾病开发差异化药物，其研究重点是经典血液学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072903282694bfe5d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072903282694bfe5d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2550659361","title":"Agios Pharmaceuticals, Inc.盘中异动 快速拉升5.15%报38.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659361","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550659361?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:52","pubTimestamp":1752072748,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时52分，Agios Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.15%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家专注于细胞代谢领域的生物制药公司，旨在为罕见疾病开发差异化药物，其研究重点是经典血液学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225229953c4723&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709225229953c4723&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2548885093","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548885093","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548885093?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:20","pubTimestamp":1751386800,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时20分，Agios Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.04%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家专注于细胞代谢领域的生物制药公司，旨在为罕见疾病开发差异化药物，其研究重点是经典血液学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702002000a4c95684&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702002000a4c95684&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2544460215","title":"Agios Pharmaceuticals, Inc.盘中异动 下午盘快速拉升5.07%报36.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544460215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544460215?lang=zh_cn&edition=full","pubTime":"2025-06-17 01:32","pubTimestamp":1750095160,"startTime":"0","endTime":"0","summary":"北京时间2025年06月17日01时32分，Agios Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.07%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家专注于细胞代谢领域的生物制药公司，旨在为罕见疾病开发差异化药物，其研究重点是经典血液学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617013241a70c8e7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617013241a70c8e7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0},{"id":"2516630865","title":"Agios Pharmaceuticals, Inc.盘中异动 快速下挫5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516630865","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516630865?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:45","pubTimestamp":1741013140,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时45分，Agios Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.41%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家专注于细胞代谢领域的生物制药公司，旨在为罕见疾病开发差异化药物，其研究重点是经典血液学。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224541abe63813&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224541abe63813&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2512207953","title":"Agios Pharmaceuticals, Inc.2024财年实现净利润6.74亿美元，同比增加291.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512207953","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512207953?lang=zh_cn&edition=full","pubTime":"2025-02-17 00:01","pubTimestamp":1739721663,"startTime":"0","endTime":"0","summary":"2月17日，Agios Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为6.74亿美元，同比增加291.48%；其中营业收入为36.50百万美元，同比增加36.09%，每股基本收益为11.86美元。机构评级：截至2025年2月17日，当前有6家机构对Agios Pharmaceuticals, Inc.目标价做出预测，其中目标均价为56.67美元，其中最低目标价为45.00美元，最高目标价为74.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000114a2481c17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217000114a2481c17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO"],"gpt_icon":0},{"id":"1158994754","title":"Agios制药公司第四季度销售额1070万美元，高于预期的933万美元，净亏损9650万美元同比相比9590万美元，现金余额15亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158994754","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158994754?lang=zh_cn&edition=full","pubTime":"2025-02-13 19:42","pubTimestamp":1739446968,"startTime":"0","endTime":"0","summary":"Agios制药公司发布了第四季度财报，报告显示销售额为1070万美元，高于预期的933万美元。公司的净亏损为9650万美元，而去年同期为9590万美元。此外，公司目前的现金余额为15亿美元。以上内容来自Benzinga Earnings专栏，原文如下：N","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO"],"gpt_icon":0},{"id":"2511546331","title":"Agios Pharmaceuticals(AGIO.US)：2024年Q4财报实现营收1070万美元，前值为710.3万美元，预期值为935万美元；每股收益为-1.94美元，前值为-1.72美元，预期值为-1.63美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511546331","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511546331?lang=zh_cn&edition=full","pubTime":"2025-02-13 19:42","pubTimestamp":1739446935,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals(AGIO.US)：2024年Q4财报实现营收1070万美元，前值为710.3万美元，预期值为935万美元；每股收益为-1.94美元，前值为-1.72美元，预期值为-1.63美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/13194248146637.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["AGIO"],"gpt_icon":0},{"id":"2504542944","title":"Agios Pharmaceuticals, Inc.盘中异动 股价大跌5.06%报31.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504542944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504542944?lang=zh_cn&edition=full","pubTime":"2025-01-17 03:37","pubTimestamp":1737056266,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日03时37分，Agios Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.06%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Aeon Biopharma, Inc.涨幅较大，Aditxt, Inc.、Phio Pharmaceuticals Corp.、Aeon Biopharma, Inc.较为活跃，换手率分别为1932.58%、1198.77%、757.69%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Aeon Biopharma, Inc.，振幅分别为152.94%、131.33%、104.84%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117033747a224a16b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250117033747a224a16b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AGIO","BK4139"],"gpt_icon":0},{"id":"2502286096","title":"Agios Pharmaceuticals, Inc.盘中异动 急速下挫5.15%报34.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2502286096","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502286096?lang=zh_cn&edition=full","pubTime":"2025-01-10 22:50","pubTimestamp":1736520612,"startTime":"0","endTime":"0","summary":"北京时间2025年01月10日22时50分，Agios Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.15%。Agios Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.87%。其相关个股中，Conduit Pharmaceuticals Inc.、Jasper Therapeutics Inc C/Wts 24/09/2026 、Moolec Science Sa C/Wts 涨幅较大，Zyversa Therapeutics, Inc.、Precision Biosciences, Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为1064.25%、178.51%、165.92%，振幅较大的相关个股有Precision Biosciences, Inc.、Zyversa Therapeutics, Inc.、Conduit Pharmaceuticals Inc.，振幅分别为39.55%、37.29%、30.12%。Agios Pharmaceuticals, Inc.公司简介：Agios Pharmaceuticals Inc 是一家生物制药公司，专注于开发针对癌症和罕见遗传代谢疾病的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110225012aba607a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250110225012aba607a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AGIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.agios.com","stockEarnings":[{"period":"1week","weight":-0.0283},{"period":"1month","weight":-0.4023},{"period":"3month","weight":-0.2836},{"period":"6month","weight":-0.2651},{"period":"1year","weight":-0.3888},{"period":"ytd","weight":-0.206}],"compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0103},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.1363},{"period":"1year","weight":0.1188},{"period":"ytd","weight":0.1583}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Agios Pharmaceuticals, Inc.于2007年8月7日在特拉华州注册成立。该公司是一家生物制药公司，致力于通过细胞代谢领域的领导地位改变患者的生活，目标是为罕见病创造差异化药物，重点是经典血液学。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.043085},{"month":2,"riseRate":0.666667,"avgChangeRate":0.057106},{"month":3,"riseRate":0.5,"avgChangeRate":-0.011652},{"month":4,"riseRate":0.583333,"avgChangeRate":0.006741},{"month":5,"riseRate":0.583333,"avgChangeRate":0.052252},{"month":6,"riseRate":0.666667,"avgChangeRate":0.045835},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.012275},{"month":8,"riseRate":0.384615,"avgChangeRate":-0.041451},{"month":9,"riseRate":0.538462,"avgChangeRate":0.042929},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.007074},{"month":11,"riseRate":0.615385,"avgChangeRate":0.033339},{"month":12,"riseRate":0.384615,"avgChangeRate":-0.054335}],"exchange":"NASDAQ","name":"Agios Pharmaceuticals, Inc.","nameEN":"Agios Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Agios Pharmaceuticals, Inc.,AGIO,Agios Pharmaceuticals, Inc.股票,Agios Pharmaceuticals, Inc.股票老虎,Agios Pharmaceuticals, Inc.股票老虎国际,Agios Pharmaceuticals, Inc.行情,Agios Pharmaceuticals, Inc.股票行情,Agios Pharmaceuticals, Inc.股价,Agios Pharmaceuticals, Inc.股市,Agios Pharmaceuticals, Inc.股票价格,Agios Pharmaceuticals, Inc.股票交易,Agios Pharmaceuticals, Inc.股票购买,Agios Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agios Pharmaceuticals, Inc.(AGIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Agios Pharmaceuticals, Inc.(AGIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}